Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive × Doxorubicin × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 23 Breast Neoplasms 15 Burkitt Lymphoma 13 Sarcoma 12 Neoplasms 12 Lymphoma 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Lymphoma, Follicular 10 Hodgkin Disease 9 Triple Negative Breast Neoplasms 8 Ovarian Neoplasms 7 Recurrence 6 Lymphoma, Non-Hodgkin 6 Endometrial Neoplasms 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Neuroblastoma 5 Neoplasm Metastasis 5 Lymphoma, B-Cell 5 Liposarcoma 5 Fallopian Tube Neoplasms 5 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Mantle-Cell 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia, Biphenotypic, Acute 4 Leiomyosarcoma 4 Ganglioneuroblastoma 4 Wilms Tumor 3 Urinary Bladder Neoplasms 3 Sarcoma, Ewing 3 Osteosarcoma 3

Interventions

Cyclophosphamide 3 fludarabine 2 Temozolomide 2 Eflornithine 2 gallium Ga 68 dotatate 1 etoposide phosphate 1 Vincristine 1 Thiotepa 1 Tamoxifen 1 Standard of Care 1 Radiotherapy 1 Nivolumab 1 Mesna 1 Isotretinoin 1 Hydrocortisone 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Drug Therapy 1 Cisplatin 1 Celecoxib 1 Carboplatin 1 CLR1404 1 Blood Specimen Collection 1 Automobiles 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡